Global Health Limited has informed the Exchange regarding a press release dated May 14, 2026, titled " press release for the fourth quarter and year ended March 31, 2026 Results".
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medanta reported strong FY2026 results with total income of INR 45,089 million, up 19.6% year-on-year. EBITDA excluding Noida grew 18.6% to INR 11,343 million with margins of 25.7%, while PAT increased 15.1% to INR 5,541 million. Q4 FY26 marked the highest ever quarterly revenue of INR 11,958 million with PAT growth of 39.7% year-on-year. The company added 623 beds during the year (20.5% growth), including the fully operational 382-bed Noida hospital inaugurated in November 2025. The Board recommended a final dividend of INR 0.50 per share. International patients revenue grew 33.2% to INR 2,780 million, while OPD Pharmacy grew 30.4% to INR 1,826 million.
Strong operational and financial performance with robust volume growth, margin improvement, and shareholder returns through dividend. The expansion with new hospitals in Noida, Ranchi, and upcoming facilities in Guwahati and Varanasi positions the company for continued growth.